ACE and type 1 diabetes mellitus: Even if there was no significant difference between the prevalence of hypertension in generally healthy donors and T1D patients (18 vs. 26%, Fig. 1), there was a difference in the frequency of use of angiotensin-converting enzyme inhibitors (Fig. 2).